Placulumab
| Placulumab
| |
|---|---|
| Identifiers | |
| CAS Number | 945781-29-3
|
| ChemSpider | none
|
| KEGG | D10320
|
| Chemical data
| |
| Chemical formula | C3404H5262N902O1036S22 |
| Molecular weight | 78.7 kg/mol
|
Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases.[1]
This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued.
References[edit]
 | This monoclonal antibody–related article is a stub. You can help WikiMD by expanding the page. |
Advertise on WikiMD — 81,000+ full articles, ~900,000 total pages, ~250 million page views. Global reach, limited time promotional rates from $1/page/day. Learn more · View stats
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
About WikiMD • Contact • Disclaimer • Privacy • Copyright • Site statistics
Some content and images may originate from Wikimedia Commons or Wikipedia and remain subject to their stated licenses. Unless otherwise noted, eligible WikiMD content is available under CC BY-SA 4.0.
WikiMD Wellnesspedia — Free health & wellness information for patients, students, and health professionals.
